GLP-1 RA use is associated with a 38% to 42% lower risk for hepatic complications, including cirrhosis, among those with MASLD and T2D.

The rapid rise of GLP-1 medications such as semaglutide and tirzepatide has transformed obesity treatment. Still, experts say medications alone are not enough to address one of the nation's most ...

A study led by scientists from the A*STAR Genome Institute of Singapore (A*STAR GIS) has uncovered how the gut microbiome can influence gene activity in the liver by acting on short stretches of ...

An athlete and nursing student was rushed into surgery after doctors thought she had appendicitis. But during surgery, they ...